Welcome to LATITUDE Pharmaceuticals
Formulation Experts for Challenging Compounds
LATITUDE Pharmaceuticals Inc. is a leading-edge formulation development contract research organization that provides innovative NCE, 505(b)(2) and generic drug formulation development services and proprietary drug delivery systems to the human and veterinary pharmaceutical industries. Since our founding in 2003, we have performed over 800 formulation development projects for over 225 client companies and have developed a world-wide reputation for creative approaches, reliability, rapid turnaround, successful formulations and client satisfaction.
LATITUDE’s focus is on the special challenges of formulation development for compounds that are highly insoluble, highly unstable, and/or have poor bioavailability. This focus has made LATITUDE a specialist with the experience and track record to tackle the toughest formulation challenges for problematic drug candidates. LATITUDE is fully capable of handling controlled substances (Schedule I-V).
LATITUDE employs a wide armamentarium of techniques and technologies, many of which are unique and proprietary, to address insolubility, instability, poor absorption, vein irritation, large/bulky doses, lack of IP protection and other formulation challenges over a wide range of pharmaceutical dosage forms.
LATITUDE also develops state-of-the-art drug delivery systems as proprietary platform formulation technologies, including our PG Depot™ injectable depots and our Nano-E™ nano-emulsions. Latitude makes these technologies available to our clients to improve the efficacy, safety, and overall therapeutic value, as well as establish new intellectual property, for their drug compounds.
In addition, LATITUDE applies its own technologies to develop improved formulations of existing drugs that can be developed as accelerated-approval 505(b)(2) NDA candidates. Contact LATITUDE for more information on these 505(b)(2) Licensing Opportunities.